Tokyo, Japan

Laurean Ilies

This inventor holds 2 USPTO granted patents. Top assignees: The University of Tokyo, Towa Pharmaceutical Co., Ltd.. Active years: 2019-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurean Ilies. Retrieved from https://idiyas.com/inventor/laurean-ilies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Laurean Ilies: Innovator in Proton Pump Inhibitor Compounds

Introduction

Laurean Ilies is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of proton pump inhibitors. His innovative methods have led to advancements in the production of optically active compounds.

Latest Patents

Laurean Ilies holds 2 patents related to the production of proton pump inhibitor compounds with optical activity. His latest patents include a method for producing a highly pure optically active proton pump inhibitor compound. This method allows for safe and inexpensive production with high yield and enantioselectivity. The process involves oxidizing a sulfide with hydrogen peroxide using an iron salt in the presence of a chiral ligand. The detailed chemical formulas and configurations are crucial for achieving the desired optical activity.

Career Highlights

Throughout his career, Laurean Ilies has worked with prestigious institutions, including the University of Tokyo and Towa Pharmaceutical Co., Ltd. His work has been instrumental in advancing pharmaceutical research and development.

Collaborations

Laurean has collaborated with esteemed colleagues such as Eiichi Nakamura and Yoji Oderaotoshi. These partnerships have further enriched his research and contributed to his innovative approaches in the field.

Conclusion

Laurean Ilies is a prominent figure in the pharmaceutical industry, recognized for his innovative methods in producing proton pump inhibitors. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…